» Articles » PMID: 16006525

Modifying Specific Cysteines of the Electrophile-sensing Human Keap1 Protein is Insufficient to Disrupt Binding to the Nrf2 Domain Neh2

Overview
Specialty Science
Date 2005 Jul 12
PMID 16006525
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

The risks of cancer and other degenerative diseases caused by reactive oxygen species and electrophiles can be reduced by the up-regulation of detoxifying enzymes. A major mechanism whereby these protective enzymes are induced occurs through activation of the antioxidant response element (ARE) by the oxidative-stress sensor protein Kelch-like ECH-associated protein 1 (Keap1) and the transcription factor NF-E2-related factor 2 (Nrf2). Under basal conditions, Keap1 sequesters Nrf2 in the cytoplasm by binding to its Neh2 domain. Chemical inducers such as sulforaphane are known to react with Keap1 cysteine residues, thereby promoting Nrf2 nuclear accumulation and hence ARE activation. A widely accepted model for Nrf2 nuclear accumulation is that modification of Keap1 cysteines leads directly to dissociation of the Keap1-Nrf2 complex. This model is based on studies with mouse proteins and has served as the experimental basis and hypothesis for numerous investigations. Through a combination of chemical, mass spectrometry, and isothermal titration calorimetry methods, we have tested the direct-dissociation model using a series of ARE inducers: sulforaphane, isoliquiritigenin, 15-deoxy-Delta12,14-prostaglandin-J2, menadione, 1-Cl-2,4-dinitrobenzene, and biotinylated iodoacetamide. Surprisingly, these data suggest that the direct disruption model for Keap1-Nrf2 is incorrect. The relative reactivity of human Keap1 cysteines was determined. In addition to the same five cysteines identified for mouse Keap1, two highly reactive and previously unobserved cysteines were identified. Based on these results, a model is proposed that should aid in the understanding of Keap1-Nrf2 signaling mechanisms.

Citing Articles

Role of oxeiptosis in disease mechanisms and therapeutic opportunities.

Bhuvaneshwari K, Harithpriya K, Ganesan K, Xu B, Ramkumar K Apoptosis. 2025; .

PMID: 40064755 DOI: 10.1007/s10495-025-02087-z.


Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health.

Shannar A, Chou P, Peter R, Dave P, Patel K, Pan Y Curr Pharmacol Rep. 2024; 11(1):6.

PMID: 39649473 PMC: 11618211. DOI: 10.1007/s40495-024-00388-6.


Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.

Huenchuguala S, Segura-Aguilar J Antioxidants (Basel). 2024; 13(9).

PMID: 39334784 PMC: 11428591. DOI: 10.3390/antiox13091125.


Potential Signal Pathways and Therapeutic Effects of Mesenchymal Stem Cell on Oxidative Stress in Diseases.

Xie Y, Zheng L, Chen W, Zeng Y, Yao K, Zhou T Curr Pharm Des. 2024; 31(2):83-94.

PMID: 39257144 DOI: 10.2174/0113816128308454240823074555.


Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism.

Ting K Front Cell Infect Microbiol. 2024; 14:1403915.

PMID: 39119289 PMC: 11306205. DOI: 10.3389/fcimb.2024.1403915.


References
1.
Wakabayashi N, Dinkova-Kostova A, Holtzclaw W, Kang M, Kobayashi A, Yamamoto M . Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci U S A. 2004; 101(7):2040-5. PMC: 357048. DOI: 10.1073/pnas.0307301101. View

2.
Levonen A, Landar A, Ramachandran A, Ceaser E, Dickinson D, Zanoni G . Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J. 2003; 378(Pt 2):373-82. PMC: 1223973. DOI: 10.1042/BJ20031049. View

3.
Kobayashi A, Kang M, Okawa H, Ohtsuji M, Zenke Y, Chiba T . Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24(16):7130-9. PMC: 479737. DOI: 10.1128/MCB.24.16.7130-7139.2004. View

4.
Kinghorn A, Su B, Jang D, Chang L, Lee D, Gu J . Natural inhibitors of carcinogenesis. Planta Med. 2004; 70(8):691-705. DOI: 10.1055/s-2004-827198. View

5.
Cullinan S, Gordan J, Jin J, Harper J, Diehl J . The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol. 2004; 24(19):8477-86. PMC: 516753. DOI: 10.1128/MCB.24.19.8477-8486.2004. View